InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Jindal Vineet R., Chief Financial Officer. Director active across 1 company, notably Reneo Pharmaceuticals, Inc.. Aggregated, 2 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €32k. Activity tracked since 25 August 2021. The latest transaction was filed on 10 December 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Vineet R. Jindal is the Chief Financial Officer of Reneo Pharmaceuticals, Inc. He oversees the financial operations and funding strategy of the company.